Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Global X SuperDividend REIT ETF
SRET
$233M
| $199K | ﹤0.01% |
+7,200
| New | +$196K |
|
|
PPBT
3652
Purple Biotech
PPBT
$1.31M
| $198K | ﹤0.01% |
+251
| New | +$162K |
|
3653
Solid Power
SLDP
$463M
| $198K | ﹤0.01% |
+22,800
| New | +$177K |
|
|
VBIO
3654
Valion Bio
VBIO
$1.29M
| $197K | ﹤0.01% |
+72
| New | +$235K |
|
3655
Yunhong Green CTI Ltd
YHGJ
$7.54M
| $197K | ﹤0.01% |
16,077
-3,550
| -18% | -$36.6K |
|
3656
Skillful Craftsman
EDTK
$14.8M
| $196K | ﹤0.01% |
156,500
+45,500
| +41% | +$59K |
|
3657
LG Display
LPL
$3B
| $196K | ﹤0.01% |
+23,755
| New | +$202K |
|
|
USER
3658
DELISTED
UserTesting, Inc.
USER
| $196K | ﹤0.01% |
+18,300
| New | +$152K |
|
3659
Xenetic Biosciences
XBIO
$5.82M
| $195K | ﹤0.01% |
19,141
-6,981
| -27% | -$72.8K |
|
3660
Inseego
INSG
$114M
| $193K | ﹤0.01% |
4,765
-6,506
| -58% | -$298K |
|
|
FTH
3661
Faeth Therapeutics
FTH
$702M
| $192K | ﹤0.01% |
+4,160
| New | +$331K |
|
3662
Protara Therapeutics
TARA
$220M
| $192K | ﹤0.01% |
37,600
-27,200
| -42% | -$143K |
|
|
ENFY
3663
DELISTED
Enlightify Inc
ENFY
| $192K | ﹤0.01% |
19,051
+7,700
| +68% | +$69.6K |
|
3664
Achieve Life Sciences
ACHV
$659M
| $191K | ﹤0.01% |
25,200
+1,400
| +6% | +$10.4K |
|
3665
TRX Gold Corp
TRX
$254M
| $189K | ﹤0.01% |
611,000
+467,274
| +325% | +$173K |
|
3666
UNIFI
UFI
$119M
| $187K | ﹤0.01% |
10,334
-27,200
| -72% | -$538K |
|
3667
iBio
IBIO
$69.5M
| $186K | ﹤0.01% |
+870
| New | +$182K |
|
3668
Lexicon Pharmaceuticals
LXRX
$1.03B
| $186K | ﹤0.01% |
+88,776
| New | +$246K |
|
3669
Tantech Holdings
TANH
$6.07M
| $185K | ﹤0.01% |
+405
| New | +$954K |
|
3670
Nuwellis
NUWE
$160K
| – | – |
0
| – | – |
|
|
TONX
3671
TON Strategy Co
TONX
$168M
| $184K | ﹤0.01% |
+24
| New | +$224K |
|
3672
Erasca
ERAS
$6.3B
| $182K | ﹤0.01% |
+21,200
| New | +$246K |
|
|
TTSH
3673
DELISTED
Tile Shop Holdings
TTSH
| $181K | ﹤0.01% |
27,600
+7,800
| +39% | +$51.2K |
|
|
SRGA
3674
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $181K | ﹤0.01% |
+19,792
| New | +$301K |
|
3675
Advantage Solutions
ADV
$522M
| $179K | ﹤0.01% |
+1,120
| New | +$194K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.